~~<i id='18B34DB0DB'><strike id='18B34DB0DB'><tt id='18B34DB0DB'><pre id='18B34DB0DB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

focus

author：knowledge 2025-08-19 18:06:43 - browse：88

It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Diagnostic tests are hitting their mathematical limits

focus

explore

hotspot

leisure time

AdobeTheFoodandDrugAdministrationonFridayannounceditsintentiontostartregulatingtestsdevelopedinlabor

WSS

UnitedHealth’s Optum accused of antitrust violations in California

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

The EPA's new lead rule: How one expert crunched the numbers

Sudafed saga points to U.S. issues with evaluating older drugs

Paxlovid should be available without a positive Covid test

UnitedHealth’s Optum accused of antitrust violations in California

leisure time

focus

focus

In Memoriam: Notable people who died in 2023

With clinical trial data readouts, here's how to spot spin

Apple is now the first public company to be valued at $3 trillion

Paxlovid should be available without a positive Covid test

Heart attack and stroke risk calculators need revising

Data show record exodus of life scientists from academia

Apple is now the first public company to be valued at $3 trillion

Health tech startups drop sharply from 2021 highs

Guidelines to prevent youth baseball injuries need more muscle

The EPA's new lead rule: How one expert crunched the numbers

explore

Medicaid, Medicare dual

Mindstrong's demise and the future of mental health care

BIO selects John Crowley as new CEO

FDA advisers vote against ALS treatment from BrainStorm

Takeda, Janssen join wearable maker to measure scratching

CDC director unscathed in first congressional testimony

hotspot

hotspot

hotspot

leisure time